Evaluation of individualized interventional therapies for patients with unresectable intrahepatic cholangiocarcinoma

Evaluation of individualized interventional therapies for patients with unresectable intrahepatic cholangiocarcinoma - CCC modern

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006237

Enrollment

Registered

2014-06-25

Start date

2013-07-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.1

Interventions

Group 1: historical: Retrospective Evaluation of clinical outcomes, and the factors influencing survival, of patients with unresectable intrahepatic cholangiocellular carcinoma (ICC) treated by a tail

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: - Patients with inoperable iCC - indication for interventional therapy - complete therapy and follow-up

Exclusion criteria

Exclusion criteria: a) Karnofsky < 60% b)Cancer of unknown primary c)second malignancy d)incomplete Follow-up

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
factors influencing survival	—

Countries

Germany

Contacts

Public ContactChristel Besseler

Klinik für Radiologie und Nuklearmedizin

christel.besseler@ed.ovgu.de+49-391-6713071

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 2, 2026